ZFP30 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.902500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.398400E-01
Normal-vs-Stage2
3.264500E-02
Normal-vs-Stage3
4.594500E-04
Normal-vs-Stage4
1.941230E-01
Stage1-vs-Stage2
1.148350E-01
Stage1-vs-Stage3
7.150100E-02
Stage1-vs-Stage4
5.535200E-01
Stage2-vs-Stage3
1.334400E-01
Stage2-vs-Stage4
8.232800E-01
Stage3-vs-Stage4
2.277200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.769900E-02
Normal-vs-AfricanAmerican
2.038800E-01
Normal-vs-Asian
1.119380E-01
Caucasian-vs-AfricanAmerican
7.548000E-01
Caucasian-vs-Asian
6.477200E-01
AfricanAmerican-vs-Asian
6.690800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.691800E-02
Normal-vs-Female
5.956100E-02
Male-vs-Female
2.961800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.974400E-01
Normal-vs-Age(41-60Yrs)
7.140000E-02
Normal-vs-Age(61-80Yrs)
4.563500E-02
Normal-vs-Age(81-100Yrs)
1.343980E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.574400E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.730300E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.960110E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.715800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.081700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.585400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.641530E-02
Normal-vs-Daily Drinker
2.455100E-03
Normal-vs-Weekly Drinker
6.741600E-03
Normal-vs-Occasional Drinker
1.076990E-01
Normal-vs-Social Drinker
1.156380E-01
Non Drinker-vs-Daily Drinker
4.348200E-01
Non Drinker-vs-Weekly Drinker
6.993200E-01
Non Drinker-vs-Occasional Drinker
2.743200E-01
Non Drinker-vs-Social Drinker
1.055560E-01
Daily Drinker-vs-Weekly Drinker
2.445200E-01
Daily Drinker-vs-Occasional Drinker
8.347600E-02
Daily Drinker-vs-Social Drinker
2.082000E-02
Weekly Drinker-vs-Occasional Drinker
5.106000E-01
Weekly Drinker-vs-Social Drinker
2.197600E-01
Occasional Drinker-vs-Social Drinker
6.500800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.031010E-01
Normal-vs-Grade 2
4.678400E-02
Normal-vs-Grade 3
2.317700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.937640E-01
Grade 1-vs-Grade 3
3.965200E-01
Grade 1-vs-Grade 4
1.031010E-01
Grade 2-vs-Grade 3
4.744400E-01
Grade 2-vs-Grade 4
4.678400E-02
Grade 3-vs-Grade 4
2.317700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.300410E-02
Normal-vs-NonDiabetic
3.608000E-02
Diabetic-vs-NonDiabetic
2.006800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.063700E-03
Normal-vs-NoPancreatitis
3.254000E-02
Pancreatitis-vs-NoPancreatitis
1.304200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.126020E-01
Normal-vs-N1
2.542200E-02
N0-vs-N1
8.949600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.149030E-01
Normal-vs-TP53-NonMutant
3.472800E-01
TP53-Mutant-vs-TP53-NonMutant
2.362200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
